Evidence map›Paper›PMID 41644866›Full record

ReviewMycopathologia2026

Fatal Ultra-Early-Onset Rhino-Cerebral Mucormycosis Caused by Rhizomucor miehei Following Umbilical Cord Blood Transplantation and Review of Published Literature.

Kumi Nitta, Shinsuke Takagi, Otoya Watanabe, Takashi Sakoh, Mika Kuno, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida and 16 more

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Kumi NittaDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Shinsuke TakagiDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan. shinsukewwwtakagi@icloud.com.
Otoya WatanabeDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Takashi SakohOkinaka Memorial Institute for Medical Research, Tokyo, Japan.
Mika KunoDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Kyosuke YamaguchiDepartment of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Kosei KageyamaDepartment of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Daisuke KajiDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Yuki TayaDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Aya NishidaDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Muneyoshi KimuraDepartment of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Hisashi YamamotoDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Noritaka KudoDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Takayuki ShinoharaDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Ami KoizumiDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Yasunori MuraosaDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Takashi UmeyamaDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Minoru NagiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Yuki Asano-MoriCenter for Long-Term Follow-Up after Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
Go YamamotoDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Atsushi WakeCenter for Long-Term Follow-Up after Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
Yutaka TakazawaDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Hideki AraokaOkinaka Memorial Institute for Medical Research, Tokyo, Japan.
Yoshitsugu MiyazakiDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Shuichi TaniguchiDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Naoyuki UchidaDepartment of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 43-year-old man with myelodysplastic syndrome underwent umbilical cord blood transplantation (CBT). On day 4 post-transplantation, he developed right periorbital pain and oculomotor nerve palsy. Brain MRI revealed fluid accumulation in the sphenoid sinus and mucosal thickening in the right maxillary sinus. Given the extraordinarily early onset and neurological involvement, fungal meningitis, including mucormycosis, was suspected, and empirical high-dose liposomal amphotericin B (10 mg/kg/day) was initiated. Nasal discharge culture yielded Rhizomucor species, later identified as Rhizomucor miehei by polymerase chain reaction (PCR). Despite aggressive antifungal therapy, the patient's neurological condition deteriorated, and he died on day 49. Autopsy confirmed extensive rhino-cerebral mucormycosis with angioinvasion, and Mucorales DNA was detected in brain tissue by quantitative PCR. To our knowledge, this represents the first reported case of R. miehei infection occurring within days after transplantation, preceding neutrophil engraftment. This case highlights the importance of recognizing mucormycosis even in the immediate post-transplant period and underscores the limitations of antifungal therapy in the absence of surgical debridement.

Indexed as

Central Nervous System Fungal InfectionsCord Blood Stem Cell TransplantationMucormycosisRhizomucorAdultAmphotericin BAntifungal AgentsBrainDNA, FungalFatal OutcomeHumansMagnetic Resonance ImagingMaleMyelodysplastic SyndromesPolymerase Chain ReactionAmphotericin BAntifungal AgentsDNA, Fungalliposomal amphotericin BMucormycosisRhino-cerebral mucormycosisRhizomucor mieheiUmbilical cord blood transplantation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.